Trends in characteristics and outcomes following primary percutaneous coronary intervention: insights from a nationwide analysis Authors: Abdulrahman Arabi, Awad AlQahtani, Salaheddin Arafa, Omar Al Tamimi, Salem Abujalala, Murad Al Khani, Mohammed Ali, Mohamed Salah Abdelghani, Mhd Baraa Habib, Mohammad Altermanini, Rajvir Singh, Raul Senor Dros, Ihsan Rafie, Mohammed Qintar, Hasan Al Tamimi, Tahir Hamid, Mohammed AlHijji, Jassim AlSuwaidi Published: 2026 ABSTRACT AbstractBackgroundPrimary percutaneous coronary intervention (PPCI) is the standard of care for ST-segment elevation myocardial infarction (STEMI). Yet, data from the Middle East on long-term national trends in procedural characteristics and outcomes remain limited. This study aimed to evaluate nationwide trends in PPCI for STEMI in Qatar over nine years (2015–2023), analyzing trends of cardiovascular risk factors, presentation management, and in-hospital outcomes of STEMI cases treated with PPCI in Qatar.MethodsWe examined 7,959 STEMI patients who underwent PPCI at Qatar Heart Hospital between 2015 and 2023. Descriptive statistics were presented as mean ± SD or proportions. One-way ANOVA and chi-square tests were used to assess temporal trends. Multivariate logistic regression identified risk factors associated with in-hospital mortality. A p-value ≤ 0.05 was considered significant.ResultsAnnual PPCI volume increased > 50% from 820 cases in 2015 to 1,264 in 2023. The mean age was 49 years, predominantly male and non-Qatari. Cardiovascular risk factors increased significantly throughout the study, while EMS utilization rose from 63% to 77%. Radial access use increased from 57% to 84%, and intravascular ultrasound from 1.4% to 10%. Door-to-balloon time at the PPCI center declined from 60 to 45 min (p = 0.001). In-hospital mortality decreased from 4.4% in 2016 to 1.5% in 2023 (p < 0.001). Predictors of in-hospital mortality included older age (OR 1.03, 95% CI 1.01–1.04), prolonged door-to-balloon time 71–80 min: OR 3.49, 95% CI 1.35–9.05; 81–90 min: OR 3.01, 95% CI 1.06–8.60; ≥91 min: OR 3.31, 95% CI 1.36–8.08), cardiogenic shock requiring IABP (OR 12.08, 95% CI 8.30–17.60), and cardiac arrest (OR 4.76, 95% CI 3.04–7.49).ConclusionsThis nine-year national PPCI registry demonstrates substantial improvements in access, procedural practice, and efficiency of STEMI care in Qatar, with marked decline in in-hospital mortality.Keywords: Primary percutaneous coronary intervention (PPCI), ST-segment elevation myocardial infarction (STEMI), Door-to-balloon time, In-hospital mortality Background Primary percutaneous coronary intervention (PPCI) is the gold-standard reperfusion strategy for ST-segment elevation myocardial infarction (STEMI) [1, 2]. Over the past few decades, care systems have been developed to reduce door-to-balloon (D2B) time and optimize procedural and post-procedural care. Studies from North America and Europe showed a significant decline in STEMI mortality [3–8]. Despite the high incidence of STEMI in the Middle East, scarce data is available on the temporal trends of the procedural characteristics and outcomes of PPCI in the Middle East. Regional registry data from the Gulf Registry of Acute Coronary Events (Gulf RACE-II) have shown that patients presenting with STEMI in the Arabian Gulf are generally younger and have a high prevalence of cardiovascular risk factors, particularly diabetes mellitus, hypertension, and smoking. These studies have also demonstrated important variations in treatment strategies and clinical outcomes across the region, suggesting that differences in healthcare systems, access to reperfusion therapy, and referral pathways may influence patterns of care and patient outcomes [9]. In recent years, Qatar has implemented a national STEMI network centered around a high-volume tertiary cardiac center, with the goal of improving timely access to PPCI and optimizing the management of acute myocardial infarction. Evaluating temporal trends in STEMI presentation, management, and outcomes within such healthcare systems is essential to assess the effectiveness of these initiatives and to identify potential areas for improvement in cardiovascular care. Therefore, the aim of the present study was to evaluate temporal trends in the clinical characteristics, management strategies, and in-hospital outcomes of patients presenting with STEMI over an extended period at a national tertiary cardiac center in Qatar. Methods Study settings Qatar has a population of around 3 million. Hamad Medical Corporation is the leading provider of secondary and tertiary medical care. All residents of Qatar are covered under national healthcare. Qatar Heart Hospital, a member of Hamad Medical Corporation, is a 145-bed hospital dedicated to providing secondary and tertiary cardiovascular care. It is located in the capital, Doha, less than 100 km from the furthest point in Qatar. It delivers more than 90% of cardiovascular inpatient services. In 2013, Hamad Medical Corporation initiated a nationwide 24/7 PPCI program in collaboration with Emergency Medical Services (EMS). All suspected MIs undergo an electrocardiogram in the field by EMS. Once the STEMI diagnosis is made, the ECG is wirelessly transmitted to the Heart Hospital (HH), and the cardiac catheterization laboratory is activated before the patient’s arrival. All STEMIs across Qatar are transferred to the heart hospital for PPCI. This study is a retrospective observational cohort analysis based on data from a prospectively maintained institutional ST-segment elevation myocardial infarction (STEMI) registry at Heart Hospital, Qatar. All consecutive adult patients (≥ 18 years) presenting with STEMI and undergoing coronary angiography between 2015 and 2023 were included. Patients who died before reaching the cardiac catheterization laboratory were excluded from the analysis. Data collection Procedural data were retrieved from the cardiac catheterization database. During each procedure, data related to patient demographics, duration of symptoms, mode of presentation (EMS vs. walk-in vs. transfer from another ED), procedural details (adjunctive therapy, angiographic findings, procedural outcomes, etc.), and door-to-balloon time (D2B) are prospectively entered into the cardiac catheterization database. The mortality data is added to the cardiac catheterization database upon hospital discharge. Ethical approval The study received approval from the Institutional Review Board (IRB) of Hamad Medical Corporation. Given the study's observational nature and the patients' anonymity, the IRB did not require written informed consent from the participants. Statistical analysis Descriptive statistics were calculated as mean ± standard deviation for continuous variables and as frequency with percentages for categorical variables. Trend analyses of demographic and clinical variables across years were conducted using one-way ANOVA and chi-square tests as appropriate. Univariate analyses student t test (Un-paired) and chi-square tests were used to see associated factors in relation to In-hospital mortality. Multivariate logistic regression analysis was used with potential confounders such as age, gender, and nationality along with other relevant available variables identified from the literature as being associated with mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction to identify risk factors associated with in-hospital mortality. Adjusted Odds Ratios, 95% C.I., and p-values are presented in the tables. A two-tailed p-value ≤ 0.05 was considered statistically significant. All analyses were conducted using IBM SPSS Statistics for Windows, Version 29.0 (IBM Corp., Armonk, NY, 2022). Results Case volume Table 1 shows the program's annual volume. In the first two years, the volume was 820 cases per year. However, due to a staff shortage in the cardiac catheterization laboratory, the volume declined by 19% from 2016 to 2018. During that time, low-risk STEMI (defined as a Thrombolysis in Myocardial Infarction [TIMI] STEMI risk score <4) [10] patients received thrombolytic therapy, while high-risk cases continued to receive primary PCI 24 hours a day. Since 2019, the annual volume has consistently surpassed 1,000 instances, reaching a peak of 1,264 cases in 2023, representing an increase of over 50% since 2015. During the COVID-19 pandemic, Qatar Heart Hospital adopted a zero-thrombolytic policy, and all STEMI cases received PPCI. We did not observe a decline in the annual volume during the COVID-19 waves of 2020, 2021, and 2022 (Fig. 1). Table 1Trends of demographic and clinical characteristics of PPCI casesYear of AdmissionNumber of patientsOverall (n = 7,959)201564520165912017642201882020191015202010062021994202298220231264P valueAge49.6 ± 10.749.6 ± 10.248.9 ± 10.549.6 ± 11.049.3 ± 11.449.1 ± 10.151.1 ± 10.849.9 ± 10.350.1 ± 10.249.9 ± 10.80.001Qatari575 (7.2%)39(6.0)48(8.1)46(7.2)62(7.6)72(7.1)68(6.8)67(6.7)78(7.9)95(7.5)0.88Female358 (4.4%)27(4.2)27(4.6)33(5.1)26(3.2)50(4.9)50(5.0)41(4.1)40(4.1)64(5.1)0.001Presentation to PPCI center5974 (75.0%)408(63.3)416(70.4)473(73.7)631(77.0)772(76.1)753(74.9)794(79.9)758(77.2)969(76.7)0.001Transfer to PPCI center1985 (25.0%)237(36.7)175(29.6)169(26.3)189(23.0)243(23.9)253(25.1)200(20.1)224(22.8)295(23.3)0.001Diabetes2436 (30.6%)157(24.3)172(29.1)208(32.4)241(29.4)288(28.4)347(34.5)316(31.8)294(29.9)413(32.7)0.001Hypertension2591 (32.6%)163(25.3)175(29.6)180(28.0)240(29.3)364(35.9)353(35.1)350(35.2)323(32.9)443(35.0)0.001Dyslipidemia313 (3.9%)14(2.2)23(3.9)23(3.6)17(2.1)36(3.5)29(2.9)31(3.1)60(6.1)80(6.3)0.001Smoking3027 (38.0%)211(32.7)208(35.2)231(36.1)324(39.5)427(42.1)408(40.6)383(38.5)361(36.8)474(37.5)0.001Chronic Kidney Disease61 (0.8%)0(0)2(0.3)2(0.3)4(0.5)11(1.1)10(1.0)11(1.1)9(0.9)12(0.9)0.10Systolic BP121 ± 22.8128 ± 25.7126 ± 25.4122 ± 22.9121 ± 21.8122 ± 24123 ± 23.8120 ± 22.1117 ± 21.4117 ± 20.30.001Diastolic BP83 ± 1782 ± 1683 ± 1685 ± 1585 ± 1584 ± 1583 ± 1682 ± 1582 ± 3281 ± 130.001Cardiac Arrest445 (5.6%)18(2.8)21(3.6)30(4.7)58(7.1)93(9.2)70(7.0)44(4.4)54(5.5)57(4.5)0.001Cardiogenic shock380 (4.8%)15(2.3)19(3.2)17(2.6)53(6.5)67(6.6)70(7.0)34(3.4)57(5.8)78(6.2)0.001Mechanical Ventilation218 (2.7%)16(2.5)20(3.4)20(3.1)19(2.3)37(3.6)26(2.6)12(1.2)33(3.4)35(2.8)0.05Type of STEMI Anterior3852 (48.4%)308(47.8)323(54.7)336(52.3)413(50.4)487(48.0)554(55.1)286(28.8)495(50.4)650(51.4)0.001 Inferior3383 (42.5%)307(47.6)248(42.0)289(45.0)369(45.0)492(48.5)420(41.7)238(23.9)455(46.3)565(44.7)0.001 Lateral144 (1.8%)21(3.3)11(1.9)11(1.7)19(2.3)14(1.4)23(2.3)7(0.7)16(1.6)22(1.7)0.02Continuous variables are presented as mean ± standard deviation and were compared using one-way ANOVA. Categorical variables are presented as frequencies and percentages and were compared using the chi-square testA p-value < 0.05 was considered statistically significant Trends of demographic and clinical characteristics of PPCI cases Continuous variables are presented as mean ± standard deviation and were compared using one-way ANOVA. Categorical variables are presented as frequencies and percentages and were compared using the chi-square test A p-value < 0.05 was considered statistically significant Central Illustration: Temporal Trends and Outcomes of the Nationwide Primary PCI Program in Qatar (2015–2023) Patient demographics Table 1 presents the trends in demographic and clinical characteristics of 7,959 STEMI patients who underwent primary percutaneous coronary intervention (PPCI) between 2015 and 2023 with a clear predominance of males and non-Qatari nationals. Traditional cardiovascular risk factors, such as diabetes, hypertension, dyslipidemia, and tobacco use, increased significantly throughout the study period. The percentage of patients arriving directly at the PPCI center by ambulance rose from 63% in 2015 to 77% in 2023. The remaining patients presented to local emergency rooms or hospitals without PPCI capacity and were subsequently transferred to the Heart Hospital. We observed a significant increase in patients presenting with cardiogenic shock and those who experienced cardiac arrest before arriving at CCL. Procedural details Table 2 presents the procedural characteristics. The use of radial access increased from 57% in 2015 to 84% in 2023. Throughout the study period, the proportion of patients with pre-PCI TIMI 0 rose from 63% in 2015 to 69% in 2023, while the proportion with TIMI III flow decreased from 18% in 2015 to 13% in 2023. More than 97% of cases achieved post-procedural TIMI III flow throughout the study. The use of Intravascular Ultrasound (IVUS) and Intra-Aortic Balloon Pump (IABP) also grew considerably, from 1.4% to 3.7% in 2015 to 10% and 8.3% in 2023, respectively. The usage of intravenous Eptifibatide and Aspiration thrombectomy (data available from 2018 onward) increased from 29% to 35% and from 13% to 25% between 2018 and 2023. Table 2Trends of PPCI procedural detailsYear of Admission201564520165912017642201882020191015202010062021994202298220231264P valuePCI accessRadial366(56.7)434(73.4)529(82.4)625(76.2)808(79.6)796(79.1)756(76.1)793(80.8)1063(84.1)0.001Femoral279(43.3)157(26.6)117(17.6)195(23.8)207(20.4)210(20.9)238(23.9)189(19.2)210(15.9)0.001Angiographic Findings Left main disease > 50%22(3.4)17(2.9)21(3.3)10(1.2)12(1.2)19(1.9)23(2.3)11(1.1)14(1.1)0.001 No obstructive disease15(2.3)10(1.7)13(2.0)11(1.3)31(3.1)16(1.6)17(1.7)25(2.5)27(2.1)0.23 Two vessels CAD201(31.2)171(28.9)168(26.2)210(25.6)261(25.7)250(24.9)250(25.2)237(24.1)318(25.2)0.06 Three vessels CAD151(23.4)127(21.5)172(26.8)174(21.2)193(19.0)186(18.5)195(19.6)155(15.8)200(15.8)0.001 Mild CAD3(0.5)3(0.5)3(0.5)4(0.5)9(0.9)6(0.6)12(1.2)14(1.4)9(0.7)0.19Pre TIMI Flow (0)377(62.9)223(63.2)145(66.5)365(67.3)537(71.6)497(67.8)480(69.0)466(70.1)603(69.3)0.001 (1)41(6.8)28(7.9)9(4.1)36(6.6)57(7.6)71(9.7)49(7.0)70(10.5)93(10.7) (2)76(12.7)36(10.2)21(9.6)45(8.3)67(8.9)43(5.9)45(6.5)39(5.9)57(6.6) (3)105(17.5)66(18.7)43(19.7)96(17.7)89(11.9)122(16.6)122(17.5)90(13.5)117(13.4)Post TIMI Flow (0)9(1.5)5(1.4)0(0)3(0.6)2(0.3)4(0.5)5(0.7)2(0.3)7(0.8)0.001 (1)2(0.3)2(0.6)0(0)5(0.9)7(0.9)3(0.4)5(0.7)2(0.3)1(0.1) (2)7(1.2)5(1.4)6(2.7)11(2.1)15(1.9)20(2.6)19(2.6)16(2.3)16(1.8) (3)585(97.0)346(96.6)213(97.3)517(96.5)747(96.9)747(96.5)710(96.1)670(97.1)872(97.3) Thrombectomy------110(13.4)197(19.4)197(19.6)193(19.4)204(20.8)321(25.4)0.001 RHC*1(0.2)0(0)0(0)11(1.3)17(1.7)11(1.1)14(1.4)10(1.0)6(0.5)0.001 IVUS**9(1.4)17(2.9)12(1.9)22(2.7)40(3.9)52(5.2)65(6.5)87(8.9)126(10.0)0.001 IABP***24(3.7)17(2.9)11(1.7)21(2.6)38(3.7)35(3.5)43(4.3)71(7.2)105(8.3)0.001Post Angio Recommendation and management Medical therapy505(78.3)467(79.0)539(84.0)651(79.4)828(81.6)779(77.4)768(77.3)806(82.1)1063(84.1)0.001 CABG26(4.0)20(3.4)24(3.7)37(4.5)45(4.4)89(8.8)87(8.8)37(3.8)66(5.2)0.001 Noninvasive assessment for the non-infarct lesion10(1.6)6(1.0)8(1.2)5(0.6)1(0.1)1(0.1)3(0.3)2(0.2)2(0.2)0.001 Staged PCI------133(16.2)194(19.1)186(18.5)182(18.2)159(16.2)222(17.6)0.001 Eptifibatide Infusion------241(29.4)300(29.6)325(32.3)306(30.8)364(37.1450(35.6)0.001 Ticagrelor------31(3.8)22(2.2)32(3.2)41(4.1)215(21.9)66(5.2)0.001 Mortality24(3.7)26(4.4)15(2.3)30(3.7)28(2.8)27(2.7)24(2.4)22(2.2)19(1.5)0.01*RHC Right Heart Catheterization, **IVUS Intravascular Ultrasound, ***IABP Intra-Aortic Balloon PumpContinuous variables are presented as mean ± standard deviation and were compared using one-way ANOVA. Categorical variables are presented as frequencies and percentages and were compared using the chi-square testA p-value < 0.05 was considered statistically significant Trends of PPCI procedural details *RHC Right Heart Catheterization, **IVUS Intravascular Ultrasound, ***IABP Intra-Aortic Balloon Pump Continuous variables are presented as mean ± standard deviation and were compared using one-way ANOVA. Categorical variables are presented as frequencies and percentages and were compared using the chi-square test A p-value < 0.05 was considered statistically significant Trends in time to hospital presentation and door-to-balloon time Since 2018, the time from symptom onset to hospital presentation has been recorded in the database. The interval from symptom onset to arrival at the heart hospital showed notable variation (P = 0.001), ranging from 207 ± 235 min in 2018 to 185 ± 207 min in 2023. For patients presenting to other healthcare facilities, this interval was longer, varying from 231 ± 280 to 283 ± 336 min over the years (P = 0.001). Door-to-balloon time at HH steadily decreased from 60.4 ± 37.3 min in 2015 to 45.5 ± 23.5 min in 2023 (P = 0.001). In contrast, door-to-balloon times for patients who presented to other hospitals remained longer throughout the years, ranging from 132 ± 69 min in 2016 to 206 ± 187 min in 2021 (P = 0.001), with no consistent trend (Table 3). Table 3Comparison of interval variables according to admission years of PPCI casesYear of Admission2015645(8.1%)2016591(7.4%)2017642(8.1%)2018820(10.3%)20191015(12.8%)20201006(12.6%)2021994(12.5%)2022982(12.3%)20231264(15.9%)P valueSymptoms onset to hospital presentation------222.3 ± 264197 ± 229201 ± 233240 ± 284196 ± 221196 ± 2280.001Symptoms onset to hospital presentation for patients presenting via EMS to HH------207 ± 235178 ± 198180 ± 190230 ± 269186 ± 198185 ± 2070.001Symptoms onset to hospital presentation for other facilities268 ± 334257 ± 300268 ± 326283 ± 336234 ± 285231 ± 2800.001Door to Balloon time at HH (Minutes)60.4 ± 37.366.6 ± 46.766.6 ± 31.271.3 ± 50.758.2 ± 41.354.6 ± 41.655.9 ± 39.551.2 ± 31.445.5 ± 23.50.001Door to Balloon time for patients presenting to other facilities (Minutes)142 ± 96132 ± 69148 ± 81160 ± 125159 ± 125164 ± 106206 ± 187164 ± 128155 ± 1300.001Continuous variables are presented as mean ± standard deviation and were compared using one-way ANOVA. Categorical variables are presented as frequencies and percentages and were compared using the chi-square testA p-value < 0.05 was considered statistically significant Comparison of interval variables according to admission years of PPCI cases Continuous variables are presented as mean ± standard deviation and were compared using one-way ANOVA. Categorical variables are presented as frequencies and percentages and were compared using the chi-square test A p-value < 0.05 was considered statistically significant Mortality Table 4 described univariate analysis to see association between demographic, clinical, and procedural factors with In-hospital mortality among patients undergoing primary percutaneous coronary intervention (PPCI). Patients who died were older than survivors (55 ± 11.9 vs. 49.6 ± 10.7 years, p = 0.001), and the mortality was higher among females (9.8% vs. 4.4%, p = 0.001). Nationality was not significantly associated with In-hospital mortality (p = 0.23).Direct presentation to a PPCI facility was associated with lower In-Hospital mortality (61.4% vs. 75.4%, p = 0.001). Diabetes and hypertension were not significantly associated with in hospital mortality, while smoking was less common among patients who died (16.3% vs. 38.6%, p = 0.001).Cardiac arrest (43.7% vs. 4.5%, p = 0.001), cardiogenic shock (24.7% vs. 4.6%, p = 0.01), and use of intra-aortic balloon pump (42.3% vs. 3.5%, p = 0.001) were strongly associated with In-hospital mortality. Door-to-balloon time was also significant (p = 0.001), with the highest mortality observed when time was ≥ 91 min (47.8%). Table 4Univariate analysis of clinical and procedural factors associated with in-hospital mortalityVariableCategoryNo Mortality7744(97.3%)Mortality215(2.7%)P valueAgeYears49.6 ± 10.755 ± 11.90.001GenderFemale337(4.4%)21(9.8%)0.001NationalityQatari555(7.2%)20(9.8%)0.23Presentation to PPCI FacilityYes5842(75.4%)132(61.4%)0.001Diabetes MellitusYes2362(30.5%)74(34.4%)0.21HypertensionYes2523(32.6%)68(31.6%)0.77SmokerYes2992(38.6%)35(16.3%)0.001Procedure Access SiteRadial6093(35.8%)77(35.8%)0.001Eptifibatide infusionYes1943(25.1%)43(20.0%)0.09Cardiac ArrestYes351(4.5%)94(43.7%)0.001Cardiogenic ShockYes357(4.6%)53(24.7%)0.01IVUSYes424(5.5%)6(2.8%)0.09Cardiogenic shock requiring IABP Yes274(3.5%)91(42.3%)0.001Door to Balloon time<=30 min592(8.6%)8(4.4%)0.00131–40 min1224(17.7%)11(6.1%)41–50 min1001(14.5%)19(10.6%)51–60 min833(12.0%)13(7.2%)61–70 min680(9.8%)14(7.8%)71–80 min456(6.6%)19(10.6%)81–90 min395(5.7%)10(5.6%)>=91 min1738(25.1%)86(47.8%)Continuous variables are presented as mean ± standard deviation and were compared using the independent samples t-test. Categorical variables are presented as frequencies and percentages and were compared using the chi-square testA p-value < 0.05 was considered statistically significant Univariate analysis of clinical and procedural factors associated with in-hospital mortality Continuous variables are presented as mean ± standard deviation and were compared using the independent samples t-test. Categorical variables are presented as frequencies and percentages and were compared using the chi-square test A p-value < 0.05 was considered statistically significant In-hospital mortality exhibited a consistent decline over the study period, decreasing from a peak of 4.4% in 2016 to 1.5% in 2023 (P < 0.001). Increased age (OR 1.03, 95% CI 1.01–1.04), prolonged door-to-balloon (D2B) times (71–80 min: OR 3.49, 95% CI 1.35–9.05; 81–90 min: OR 3.01, 95% CI 1.06–8.60; ≥91 min: OR 3.31, 95% CI 1.36–8.08), cardiac arrest (OR 4.76, 95% CI 3.04–7.49), and cardiogenic shock requiring IABP (OR 12.08, 95% CI 8.30–17.60) were significantly associated with higher in-hospital mortality. Conversely, a history of smoking (OR 0.44, 95% CI 0.28–0.68) and the use of radial access (OR 0.36, 95% CI 0.25–0.52) were significantly associated with reduced in-hospital mortality. No significant associations with mortality were observed for gender, diabetic status, or the site of initial presentation (Heart Hospital vs. other facilities), as detailed in Table 5. Table 5Multivariate logistic regression analysis of predictors of in-hospital mortalityVariableCategoryAdjusted OR95% C.I.P valueAge in years--1.031.01–1.040.001GenderFemale1Male0.590.31–1.110.10NationalityNon-Qatari1Qatari0.930.50–1.750.82Presentation to non PPCI FacilityYes1Presentation to PPCI FacilityYes1.360.84–2.220.22Diabetes MellitusYes0.870.60–1.300.50HypertensionYes0.800.54–1.200.27SmokerYes0.440.28–0.680.001Procedure Access SiteFemoral1Radial0.360.25–0.520.001Eptifibatide infusionYes1.010.67–1.530.95Cardiac ArrestYes4.763.04–7.490.001Cardiogenic ShockYes1.250.77–2.040.37IVUS0.500.19–1.370.18Cardiogenic shock requiring IABP 12.088.30–17.600.001Door to Balloon time<=30 min131–40 min0.970.36–2.620.9441–50 min2.130.85–5.360.1151–60 min1.860.70–4.940.2161–70 min1.880.71–4.980.2171–80 min3.491.35–9.050.0181–90 min3.011.06–8.600.04>=91 min3.311.36–8.080.009Multivariate logistic regression analysis was performed to identify independent predictors of in-hospital mortality. Results are presented as odds ratios (OR) with 95% confidence intervals (CI). Variables included in the model were: age, gender, nationality, presentation site, diabetes mellitus, hypertension, smoking status, access site, eptifibatide use, cardiac arrest, cardiogenic shock, IVUS use, IABP use, and door-to-balloon time categories. The reference categories were: female sex, non-Qatari nationality, presentation to non-PPCI facility, femoral access, absence of risk factor, and door-to-balloon time ≤ 30 minA p-value < 0.05 was considered statistically significant Multivariate logistic regression analysis of predictors of in-hospital mortality Multivariate logistic regression analysis was performed to identify independent predictors of in-hospital mortality. Results are presented as odds ratios (OR) with 95% confidence intervals (CI). Variables included in the model were: age, gender, nationality, presentation site, diabetes mellitus, hypertension, smoking status, access site, eptifibatide use, cardiac arrest, cardiogenic shock, IVUS use, IABP use, and door-to-balloon time categories. The reference categories were: female sex, non-Qatari nationality, presentation to non-PPCI facility, femoral access, absence of risk factor, and door-to-balloon time ≤ 30 min A p-value < 0.05 was considered statistically significant Discussion In this nine-year national database, involving approximately 8000 PPCI cases, we analyzed the trends of cardiovascular risk factors, presentation management, and in-hospital outcomes of STEMI cases treated with PPCI in Qatar. We observed an increase in the number of STEMI patients undergoing PPCI during the study period which could be due to substantial increase of Qatar population as the growth was increased by approximately 22% between 2015 and 2023, increasing from roughly 2.43 million to 2.98 million [11]. We have also observed a rise in the number of patients arriving by ambulance likely due to improvements in public awareness of myocardial infarction symptoms and the development of an organized national STEMI network. In addition, there was a marked increase in the use of radial access along with decreases in door-to-balloon time and symptom-to-door time. this was accompanied by a significant decline in in-hospital mortality. Heart Hospital (HH) functions primarily as a tertiary cardiac referral center in Qatar and receives STEMI patients mainly through two pathways: direct transport by emergency medical services (EMS) or transfer from other healthcare facilities. Self-referral or walk-in presentations directly to HH are extremely rare (< 1%).In most cases, patients who present independently with chest pain are evaluated initially at the main emergency departments of general hospitals, where STEMI is diagnosed and the patient is subsequently transferred to HH through the national STEMI referral network. Furthermore, pre-hospital electrocardiogram (ECG ) is equipped in the national ambulance service, which allows for early identification of STEMI and direct transport to the PPCI-capable center. The average age of patients in our population is 49 years, which is significantly younger than patients in registries from the USA and Europe (62 and 63 years respectively) [7, 12]. This partly reflects Qatar’s relatively young population (median age 34 years) [13], driven by the large influx of young expatriate workers, predominantly males. Presentation modes for STEMI patients differ widely across regions, with EMS arrival rates ranging from as low as 12% in some Gulf area studies to over 60% in North America. In our study, the percentage of patients arriving by EMS increased over time, reaching 78%. This upward trend likely indicates the effectiveness of the Ministry of Public Health’s campaigns to boost public awareness about the importance of EMS utilization [14–18]. Observational studies and subgroup analyses of randomized trials have shown lower in-hospital mortality with IVUS-guided PPCI compared to angiography-guided PCI [19]; however, its use in the USA remains low. In a study of more than 809,000 STEMI patients undergoing PPCI, IVUS use increased from 4.2% in 2012 to 5.6% in 2017 (p < 0.0001) [20]. In our study, we observed a rapid increase in the use of IVUS guidance during PPCI, from 1.4% in 2015 to 10% in 2023. We believe we are the first in the region to report national data on the use of IVUS in PPCI. The transradial access (TRA) approach has been shown to improve outcomes in meta-analyses of randomized trials [21]. Although it offers clear advantages, the use of transradial access for PCI in the USA has progressed slowly. A decade-long study of approximately 7 million PCI procedures revealed that only 40.4% used radial access, with rates increasing from 20.3% in 2013 to 57.5% in 2022 [22]. In our study, TRA adoption was high and showed a steady upward trend, rising from 57% in 2015 to 84% in 2023. Importantly, this increase was not linked to longer D2B times, likely due to the high level of expertise and procedural familiarity among operators and catheterization laboratory staff at our high-volume center. Studies have shown that D2B time under 90 min is strongly associated with better survival, and this benefit remains even when the interval is reduced to less than 60 min [23]. However, achieving this goal remains a challenge. In a U.S. registry of 114,871 STEMI patients, the median treatment time rose from 86 min in 2018 to 91 min in 2021 for those arriving at PPCI-capable hospitals. Meanwhile, only 17% of patients requiring interhospital transfer achieved the D2B target of ≤ 120 min [24]. Our study showed a significant decrease in D2B time for patients arriving at the PPCI center by ambulance, with an average of 45 min in 2023. This improvement indicates better care coordination at the Heart Hospital, with full use of pre-hospital EMS ECG transmission, enabling early activation of the catheterization lab and team mobilization before the patient arrives. Conversely, D2B times for patients needing interhospital transfer remain above the target, likely because of factors outside the healthcare system, such as traffic and transportation; however, this calls for further review to develop better strategies for meeting treatment goals. The mortality rate for STEMI in neighboring countries varies considerably. For example, in the Gulf Coast registry, which included 1039 STEMI cases across 29 hospitals in the Arabian Gulf region between 2012 and 2013, the in-hospital mortality rate was 7.4% (ranging from 3.8% in Kuwait to 11.9% in Oman) [25]. Similar in-hospital mortality (5.7%) was reported in another study of 2,928 patients with acute STEMI from 36 hospitals across 6 Arabian Gulf countries in 2014 -2015 [18]. Our study showed that in-hospital mortality in 2015 was similar to the data reported in previous studies, with a significant decrease over the years, reaching 1.5% in 2023. We believe that the decline in mortality results from improved overall in-hospital management, reduced D2B times, increased use of TRA and IVUS, and greater EMS utilization, which in turn has led to shorter times to treatment (Table 5). In our multivariate analysis, increasing age, prolonged door-to-balloon time, cardiac arrest, and the need for intra-aortic balloon pump support were independently associated with higher in-hospital mortality. These findings are consistent with previous studies demonstrating that advanced age and delayed reperfusion are major predictors of adverse outcomes in STEMI patients undergoing primary PCI. Large registries such as the GRACE study have identified age as a strong predictor of mortality [26], while delayed treatment has been associated with increased mortality for every 30-minute delay in reperfusion. Although door-to-balloon (D2B) time remained significantly longer among patients transferred from non-PPCI centers compared with those presenting directly to the Heart Hospital, the site of initial presentation was not associated with a difference in in-hospital mortality. After adjustment for potential confounders, D2B time was not an independent predictor of mortality. This finding may be explained by the relatively younger age of our study population, which may reduce the impact of reperfusion delays. In addition to that, patients transported directly by ambulance may represent a clinically sicker group, as individuals with more severe symptoms are more likely to activate emergency medical services rather than present independently to other healthcare facilities. Conversely, the use of transradial access was associated with lower mortality, consistent with randomized trials such as the MATRIX study demonstrating improved outcomes with radial compared with femoral access [27]. There are some limitations to our study. First, due to Qatar’s dynamic population, some population changes not captured in our study may exist. Second, because of the study design, variables added to the database during the study period, such as symptoms to presentation time and the use of aspiration thrombectomy, were not recorded before 2018. Third, the study only assessed in-hospital mortality and did not consider long-term outcomes. Our study stands out in several ways. First, it utilizes national-level data for all PPCI procedures in Qatar, ensuring its representativeness of actual practice. Second, to our knowledge, it is the first study in the region to describe the national trend over time for PPCI outcomes. Finally, the data were collected and entered prospectively into the cardiac catheterization database. Conclusion Over a nine-year nationwide PPCI dataset from Qatar, we noted a marked rise in patients arriving by ambulance, increased use of transradial access and intravascular ultrasound, reduced door-to-balloon times, and a significant decline in mortality. Acknowledgements The authors would like to thank the staff of Heart Hospital, including the cardiac catheterization laboratory team and Emergency Medical Services personnel, for their support in patient care. Abbreviations Primary percutaneous coronary intervention ST-segment elevation myocardial infarction Door-to-balloon Emergency Medical Services Myocardial infarction Electrocardiogram Intravascular Ultrasound Intra-Aortic Balloon Pump Authors' contributions A.A. and A.AQ. wrote the main manuscript text and supervised the project. S.A. and O.A.T. assisted with literature review and drafting. S.AB. and M.AK. collected and curated the clinical data. M.A., M.S.A., M.B.H., and M.A.M. prepared figures. R.Si. and R.SD. provided statistical support and critical revision. H.A.T., T.H., I.R., and M.Q. contributed to study design and interpretation. M.A.H. and J.A. provided final critical revisions Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Publication of this work was supported by the Medical Research Center of Hamad Medical Corporation. Data availability The datasets used and/or analyzed during the current study are available from the corresponding author on request. Declarations Ethics approval and consent to participate This study was approved by the Medical Research Center of Hamad Medical Corporation (MRC No. 01-21-1030). Given the retrospective observational design and the fact that no intervention was invloved, the requirement for informed consent was waived by the Institutional Review Board. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets used and/or analyzed during the current study are available from the corresponding author on request.